Adcendo raised €31M in Series A extension funding led by Pontifax Venture Capital, and existing investors Novo Holdings and Ysios Capital.

Biotech Health services

Denmark

Netherlands

Sweden

United States

Spain

Israel

Investments

02 April 2023

Share:

Adcendo (company)

Denmark

Biotech Health services

Total investments received (USD): 318.72m

Round value (USD): 33.96m

Round investors: Gilde Healthcare HealthCap Novo A/S RA Capital Management Ysios Capital Pontifax Venture Capital

Company: Adcendo

Industry: Biotech Health services

Related deals

Acesion Pharma secured €45 million in Series B funding led by Canaan and Alpha Wave, joined by Global BioAccess Fund and Novo Holdings.

Biotech Health services Pharma

Denmark

Israel

United States

Investments 01 October 2023

Hoba Therapeutics in a €23m series A equity round with Novo Holdings, Innovationsfonden, Eifo and Eir Ventures.

Biotech Health services

Denmark

Sweden

Italy

Japan

Investments 01 October 2023

Bactolife in a €30m Series A funding led by ATHOS, with participation from the Bill & Melinda Gates Foundation,.

Biotech Health services Manufacturing

Denmark

Germany

United States

Investments 03 August 2023

Teitur Trophics scores €28 million in Series A funding round led by Sunstone Life Science Ventures and Sound Bioventures.

Biotech Health services

Denmark

Sweden

Finland

Norway

Investments 05 March 2023

Minervax in a €22 million equity round backed by Trill Impact Ventures and Pureos Bioventures

Biotech Health services

Denmark

United States

Sweden

Switzerland

France

United Kingdom

Investments 10 December 2022